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Abstract 
 
Aim: To assess whether stimulus-induced modifications of electromyographic activity 
observed on scalp EEG have a prognostic value in comatose patients after cardiac 
arrest.  
 
Methods: 184 adult patients from a multi-centric prospective register who underwent 
an early EEG after cardiac arrest were included. Auditory and somatosensory 
stimulation was performed during EEG-recording. EEG reactivity (EEG-R) and EMG 
reactivity (EMG-R) were retrospectively assessed visually by board-certified 
electroencephalographers, and compared with clinical outcome (cerebral performance 
category, CPC) at three months. A favorable functional outcome was defined as CPC 
1-2, an unfavorable outcome as CPC 3-5. 
 
Results: Both EEG-R and EMG-R were predictors for good outcome (EEG-R: 
accuracy 72% (95%-CI: 66-79), sensitivity 86% (78-93), specificity 60% (50-69); 
EMG-R: accuracy 65% (58-72), sensitivity 61% (51-75), specificity 69% (60-78)).  
When reactivity was defined as EEG-R and/or EMG-R, the accuracy was 73% (67-
70), the sensitivity 94% (90-99), and the specificity 53% (43-63). 
 
Conclusion: Taking EMG into account when assessing reactivity of EEG seems to 
reduce false negative predictions for identifying patients with favorable outcome after 
cardiac arrest. 
 
Keywords: cardiac arrest; coma; prognostication; EEG; EMG; reactivity 
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1. Introduction  
 
Prognostication in comatose patients after cardiac arrest (CA) remains a challenging 
task for clinicians in the intensive care unit [1]. One of the main diagnostic and 
prognostic tools is the electroencephalogram (EEG). While the vast majority of 
existing prognostic modalities target identification of subjects with poor outcome [1], 
several EEG features have been shown to be associated with either favorable or 
unfavorable outcome. EEG reactivity (EEG-R), namely the modification of EEG 
background following external stimulation, has been recognized as a predictor for 
good prognosis in comatose patients at the intensive care unit [2,3], in particular for 
patients with hypoxic/anoxic encephalopathy after CA [4–9]. There is however no 
uniform definition of EEG-R. For instance, recommendations of the American 
Clinical Neurophysiology Society define reactivity as a “change in cerebral EEG 
activity to stimulation (...), [which] may include change in amplitude or frequency, 
including attenuation of activity” [10]. By contrast, appearance of rhythmic or 
periodic patterns after stimulation (“SIRPIDs”) is considered a predictor for poor 
functional outcome [11].  
 
Besides cerebral activity, scalp-EEG electrodes often register electromyogram (EMG) 
activity, especially on the frontal and temporal regions - due to the tonic and phasic 
contraction of the frontal and temporal muscles [12]. Usually, electromyographic 
reactivity (EMG-R), that is modifications of the muscle activity after stimulus, is not 
taken into account in the definition of reactivity [10]. This point was explicitly 
addressed in a recent consensus survey, in which 88% of the 24 international EEG 
experts who participated declared that EMG-R should not qualify as EEG reactivity 
[3]. Currently, EMG activity in comatose patients after CA is rather considered as an 
artifact, that if too abundant may be suppressed pharmacologically [13] or with 
computational methods [14] to ensure better interpretation of the EEG.     
 
However, muscle activity is regulated by the central nervous system, and varies with 
different vigilance states, both in physiological and pathological conditions; for 
example muscle atonia is a hallmark of Rapid-Eye-Movement sleep [15]. Motor 
response to pain (visually assessed, for instance within the Glasgow Coma Scale) is a 
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predictor for outcome after CA [16]. Frontalis EMG was used for arousal detection 
during general anesthesia [17], and currently several proprietary algorithms for 
monitoring sedation depth based on EEG incorporate high frequencies (> 30Hz) [18] , 
which on the scalp mainly correspond to muscle activity.  
 
In this paper, we systematically investigate the prognostic value of EMG-R observed 
during scalp-EEG, either isolated or in conjunction with EEG-R, for identifying 
patients with good outcome in the early phase after cardiac arrest. 
 
2. Methods 
 
Patients and treatment 
Patients were recruited in the Intensive Care Department of two university hospitals 
in Switzerland, in Lausanne (Centre Hospitalier Universitaire Vaudois) and Bern 
(Inselspital). The cohort was part of a prospective multi-centric register [4]. The study 
protocol was approved by the ethical commissions of each hospital (number VD-
116/13). For the present study, we included comatose patients after cardiac arrest 
(CA) who underwent an EEG during controlled normothermia (CNT) at 36°C. The 
recruitment period in Lausanne was from January 2015 (establishment of controlled 
normothermia) until March 2017; since recruitment in Bern started later (June 2016), 
we extended the recruitment period for 6 months (until September 2017). Recruitment 
periods were determined before start of the analysis.  
 
CNT was performed using ice packs or intravenous ice-cold fluids together with a 
feedback controlled cooling device (Arctic Sun System, Medivance, Louisville or 
Thermogard XP, ZOLL Medical, Zug, Switzerland) for 24h. During CNT either 
propofol (4 mg/kg/h) or midazolam (0.1 mg/kg/h) and fentanyl (1.5 μg/kg/h) were 
given for analgesia and sedation, and vecuronium, rocuronium, or atracurium for 
controlling shivering if needed. In Lausanne, three patients were given myorelaxants 
during EEG recording to reduce artifacts. 
  
Decision to remove life supporting treatment was taken 72h after CA or later, if two 
of the following criteria were met 1) unreactive EEG background in a recording 
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performed at least 36h after CNT and off sedation, 2) treatment-resistant myoclonus, 
3) bilateral absence of N20 in SSEP, 4) incomplete return of brainstem reflexes [4]. In 
Bern, an additional criteria for withdrawal of intensive care support was the 
association of extensive hypoxic/ischemic lesions on the MR-scan with a serum 
neuron-specific enolase level twice above 33 μg/l. 
 
The clinical outcome was prospectively assessed with the Cerebral Performance 
Category (CPC) [19] at three months, by phone interview. A CPC value of 1 (no 
deficits) or 2 (minor deficits) was considered as a favorable outcome, whereas a CPC 
of 3 (severe deficits), 4 (vegetative state) or 5 (death) was considered an unfavorable 
outcome).  
 
EEG recordings 
All EEGs were performed during CNT. At the Lausanne University Hospital, Video-
EEG (Viasys Neurocare, Madison, WI) recordings were performed for 20–30 min 
with 19 electrodes according to the international 10-20 system, with reference placed 
near FpZ. The sampling rate was usually 250Hz, in a few cases 1000 Hz. Recordings 
were available to treating clinicians for detection and treatment of epileptic seizures, 
but were not taken into account for the decision to continue or withdraw treatment on 
the third day. At the Bern University Hospitals EEGs were performed at 1200 Hz 
using a 63 active ring electrode array (g.HIamp, g.tec medical engineering, Graz, 
Austria) using the 10-10 system, referencing to the right ear lobe. Only the electrodes 
from the 10-20 system were considered in the present study. Recordings in Bern were 
performed in the context of a research project involving a mismatch negativity 
paradigm [20,21], after which 10 minutes of baseline EEG and then EEG during 
stimulations were recorded. Traces were not available to treating clinicians, however 
a minority of patients underwent an additional EEG shortly before or after the study 
EEG in case of clinical suspicion of seizures.  
 
Stimulation and reactivity 
Stimulation was performed with repetitive auditory stimuli (usually calling the 
patient’s name, then hand clapping) and somatosensory stimuli (combining peripheral 
stimuli such as finger nail compression, and central stimuli such as bilateral nipple 
pinching or sternum friction) by a certified EEG-technician (Lausanne), or a board-
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certified neurologist (Bern). Passive eye opening was not taken into account for 
determining reactivity, as this procedure was not systematically performed on all 
patients. In both centers, beginning and end of stimulus (lasting from 1 to several 
seconds) was marked during the recording. 
 
Three board-certified electroencephalographers (MC, AS, and FZ) blind to clinical 
outcome performed the visual analysis for reactivity retrospectively. By default, a 4th 
order Butterworth band-pass filter between 0.5 and 70 Hz was applied, and the EEG-
traces were displayed on 10-second epochs using a longitudinal bipolar montage. 
However, the examiners were allowed to modify the settings if desired, and were free 
to use a notch filter 48-52 Hz. EEG-R was defined as a clear modification of the 
amplitude and/or the frequency of the EEG background occurring during or at most 3 
seconds after the application of the stimulus. Appearance or modification of periodic 
or rhythmic patterns, as defined by the ACNS guidelines [10], in absence of 
background modification, was not considered as EEG-R. EMG-reactivity (EMG-R) 
was defined as a clear modification of amplitude of the muscle activity, or of the 
number of channels on which muscle activity was seen. To enforce these criteria, 
examiners were not asked to judge the presence or absence of reactivity, but to report 
separately the effect of auditory and of somatosensory stimulus on 1) the amplitude of 
EEG background, 2) the frequency of EEG background and 3) the EMG activity 
using the categories increase, decrease or no modification clearly attributable to 
stimuli. Each recording was analyzed independently by two examiners (each 
examiner was attributed randomly 2/3 of recordings); in case of disagreement, a 
consensus was reached and/or the opinion of the third examiner was required.   
 
In addition, background EEG continuity was visually assessed according to [10]. In 
particular, we considered two sub-groups of EEG patterns. Firstly, with either a 
continuously suppressed background (with or without superimposed periodic 
patterns) or a burst-suppression (defined as >50% of the traces <10 μV). In 
accordance with the terminology introduced by Westhall et al [22], we called this sub-
group “highly malignant pattern” (even though the original description was made in 
recordings performed at least 72h after CA). Secondly, the sub-group consisting of 
EEGs with continuous background or only stimulus-induced suppression/attenuation.  
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Statistics 
The primary goal of this study was to compare the sensitivity and specificity for good 
outcome of reactivity defined as a modification of EEG background (EEG-R) versus 
reactivity defined as a modification of EEG background and/or modification of EMG 
activity (EEG-R and/or EMG-R). Differences in sensitivity and specificity were 
assessed with a McNemar test (performed on patients with favorable outcome and 
unfavorable outcome, respectively). Pairwise agreement between examiners was 
assessed with Cohen’s κ, whereby only the presence (and not the type) of 
modifications was considered. For patients’ demographics, differences between 
groups were assessed with Mann-Whitney-U tests for numerical values and with Chi-
square tests for categorical data. Statistical analysis was performed with the Machine 
Learning and Statistics Toolbox from Matlab R2017a (Version 9.2, Matworks, 
Natwick, MA) for Mann-Whitney-U and Chi-square tests, and with SPSS (Version 
25, IBM, Armonk, NY) for McNemar’s test and Cohen’s κ. 
 
3. Results 
 
During the recruitment period, 144 patients from Lausanne and 40 patients from Bern 
were included (total 184, 45 women). The mean age (± SD) was 63.4 (± 15.0) years. 
90 patients had favorable, and 94 patients unfavorable outcome at three months (of 
which 82 died). All EEGs were recorded during CNT; the mean latency was 21 (±7) 
hours after CA. The patients’ demographics are shown in Table 1. 
 
115 recordings showed EEG reactivity (EEG-R); 84 recordings showed EMG 
reactivity (EMG-R), from which 70 with presence of EEG-R and 14 in absence of 
EEG-R (typical examples are presented in Figure 1); 129 recordings showed at least 
one type of reactivity (EEG- and/or EMG-R). The inter-rater agreement for EEG-R 
was 87% (κ: 74), for EMG-R 83% (κ: 65). The resulting inter-rater agreement for 
reactivity defined as EEG- and/or EMG-R was 91% (κ: 78).  
 
The performance of the different types of reactivity for predicting clinical outcome is 
presented in Table 2. As expected, EEG-R was a predictor for favorable outcome, 
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whereby the sensitivity was higher than the specificity. EMG-R alone was also a 
predictor for favorable outcome, however the accuracy was slightly lower. Finally, 
combining EEG-R and/or EMG-R lead to a significant increase of sensitivity 
compared to EEG-R alone (94% vs. 86%, p = 0.008, McNemar), at the cost of a lower 
specificity (53% vs. 60%, p=0.03, McNemar). Accordingly, the negative predictive 
value (NPV) increased from 81% to 91% (whereas accuracy and positive predictive 
value were not affected).  
 
Combining background reactivity and continuity 
Table 3 shows the influence of EMG-R when reactivity was associated to background 
EEG continuity for prognostication. A continuous background was often associated 
with favorable outcome; however, the sensitivity was low. Also considering EEG-R 
as marker for favorable outcome (continuous background and/or EEG-R) 
considerably increased the sensitivity; including EMG into the definition of reactivity 
further increased it.  
 
Burst-suppression and a continuously suppressed background, collectively referred to 
as “highly malignant pattern”, were both strongly associated with unfavorable 
outcome. However, six patients with burst suppression had a favorable outcome. All 
six had non-identical bursts (as defined in [23]) and no highly epileptiform bursts [10] 
- and all showed one type of reactivity (two had EEG-R and the remaining four had 
EMG-R; no patient showed both reactivities). As such, adding the absence of 
reactivity as necessary criterion increased the specificity for unfavorable outcome 
from 93% to 96% for EEG-R, and to 100% for EEG-R and EMG-R.  
 
4. Discussion 
 
This retrospective analysis of prospectively collected EEG in comatose patients after 
CA shows that taking changes of muscle activity into account when judging reactivity 
of an EEG trace increased significantly the sensitivity for good outcome.  
 
Currently, most guidelines recommend to discard muscle activity when judging 
reactivity on scalp EEG [10,16], However we show, to the best of our knowledge for 
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the first time, that EMG-R can contribute meaningfully to prognostication after 
cardiac arrest. When considered alone, changes in EMG activity after stimulus 
correctly predicted the outcome for about two-thirds of patients. The benefit of EMG-
R was greater when combined with “classical” EEG-R.   
 
These results are of relevance for clinicians confronted with the decision to continue 
or withdraw intensive care support in comatose patients after CA. For outcome 
prediction based on reactivity, consequences of a false negative (falsely predicting 
that a patient will not have a favorable outcome, when he actually would) are 
undoubtedly more harmful than a false positive (falsely predicting good outcome for a 
patient who in fact will have a poor functional outcome). Using EEG and/or EMG-R 
instead of EEG-R alone reduced the percentage of errors (false negatives) in patients 
with absence of reactivity from 19 % to 9 % (1-NPV).   
 
Also when reactivity was combined with another important feature of EEG analysis, 
namely background continuity, inclusion of EMG-R could reduce false negatives for 
detecting favorable outcome (or false positives for detecting unfavorable outcome). 
 
Physiological and practical aspects of EMG-R  
Several mechanisms might explain why EMG-R brings additional information to 
EEG-R when interpreting reactivity. One obvious reason is that the presence of EMG 
activity can impair EEG interpretation (“muscle artifacts”). In these cases, judging 
reactivity on EMG increases the signal-to-noise ratio. Conversely, EMG-R is difficult 
to assess when very little EMG activity is present, a situation which usually improves 
the EEG readability. Because of this complementarity and conflicting requirements 
for EEG- or EMG-quality, examiners in this study disagreed on both EEG-R and 
EMG-R in only 4 subjects. 
 
We also observed that the EMG baseline (that is, in absence of stimulation) was often 
more stable than the EEG baseline. Moreover, stimulus-induced EMG-modifications 
lasted often longer than EEG-modifications. This point is illustrated in Figure 1a: it is 
possible that the nociceptive stimulus did induce a flattening of the EEG, but this 
flattening was also observed every few seconds during baseline condition 
(discontinuous EEG). By contrast, in the same example, EMG activity was not 
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present before the stimulus, and persisted for almost one minute after the stimulus. 
EEG background can also be difficult to assess for other reasons, for instance in 
presence of periodic patterns or epileptiform activity (Figure 1b).  
 
EEG-R contributes to prognostication by assessing afferent (sensory) pathways, 
thalamic relays and the cerebral cortex [24]. By contrast, EMG-R does not necessarily 
require cortical activation, but requires functional efferent pathways at the brain stem 
level (cranial nerves V and VII for temporal and frontal muscles, respectively). One 
can postulate that in a few cases in which the cortical activity was still recovering 
after the anoxic-ischemic phase, or still severely impaired by sedation during CNT, 
EMG-R could help identify patients with a still functioning brainstem.  
 
Strengths and limitations 
We investigated a relatively large number of patients from a prospectively acquired 
and well characterized multi-centric cohort. Each stimulus modality was performed at 
least twice. The requirement to describe specifically the effect of stimulation on 
amplitude and frequency of EEG activity resulted in a high inter-rater agreement, 
which was comparable to or higher than in previous studies [25,26]. The transposition 
to “real-world” conditions is supported by the fact that no patient was excluded due to 
EEG artifacts.  
 
In this study we analyzed early EEGs performed during CNT. The reasons are, first, 
that early EEGs seem to have a better predictive value for good outcome [9,27], and 
second, that these EEGs were not taken into account for the final decision to continue 
or withdraw intensive care support. However, the timing of the EEG varied between 5 
and 30 hours after CA. This constitutes a limitation, as EEGs are known to vary 
during the first 30 hours after CA [9,28]. In particular, burst-suppression [28] or a 
suppressed background [9] can be observed early even in patients with favorable 
functional outcome, whereas at 72h after CA and after rewarming they are more 
specifically associated with unfavorable outcome [22,29]. In our cohort, no patient 
with suppressed background had a favorable outcome, as opposed to six patients with 
burst-suppression. It is known, however, that burst-suppression is a heterogeneous 
group (subcategories are for instance burst-suppression with or without identical 
bursts [23], highly epileptiform vs. not highly epileptiform bursts [10]). Our results 
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suggest that a combination of EEG-R and EMG-R can help reduce false positive 
prediction of poor prognosis in case of early burst-suppression without identical or 
highly epileptiform bursts (a pattern possibly due to early EEG, or to sedation). 
Follow-up studies are needed to better assess the benefit of EMG-R for 
prognostication at 72h after CA. 
 
A limitation of our study is that the administration or not of myorelaxants could only 
be retrieved in 144/184 patients, but since myorelaxants were administrated in a 
minority of patients during CNT (<10 %) this factor is unlikely to represent a relevant 
bias. As a surrogate we analyzed the proportion of patients with baseline EMG 
activity (prior to stimulation), which was not significantly different between patients 
with favorable or unfavorable outcome. Another possible limitation of our study is 
that visual stimuli were not taken into account, since it was not routinely performed in 
Bern; moreover stimulations in Bern were not always performed in the same 
standardized way than in Lausanne [30]. Finally, we only combined reactivity with 
one other aspect of EEG background, namely continuity. The additional value of 
EMG-R compared to EEG-R alone in relation to other elements of EEG analysis 
remains to be investigated.    
 
 
Conclusion and outlook 
Based on the results of our study, we propose that EMG should be considered in the 
assessment of reactivity. In particular in cases where EEG-R was difficult to interpret 
due to artifacts or non-stationarity, EMG-R could help reduce false negative for good 
outcome. However, our study was conducted on EEGs recorded early and within a 
relatively large time-window. Whether the complementarity of EMG-R and EEG-R 
holds 72h after CA and in absence of sedation remains to be confirmed. 
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Figure 
 
Figure 1: Examples of electromyographic reactivity (EMG-R) in absence of clear 
electroencephalographic reactivity (EEG-R). Longitudinal bipolar montage, 10-
second epochs, vertical bar = 100 μV. Timing of stimuli application is marked in 
green. (a) EEG of a 66-year old male, favorable outcome (CPC 1), recorded 19 h after 
CA. Appearance of muscle activity mainly on right frontal regions after release of a 
peripheric somatosensory stimulus (finger pinching) applied for about 7 seconds, 
discontinuous EEG without clear modification following stimulation. (b) EEG of a 
42-year old female, favorable outcome (CPC 2), recorded 26 h after CA. Clear 
reduction in tonic muscle activity after auditory stimulus (2 x call of patients name). 
The epileptiform activity prevents clear appreciation of EEG background reactivity. 
(c) EEG of a 73-year old female, favorable outcome (CPC 2), recorded 28 h after CA. 
Despite bolus of tracrium before recording a clear increase of muscle activity in 
response to finger pinching is seen (d) EEG of a 60 year old male, unfavorable 
outcome (CPC 5), recorded 14 h after CA. Increase of tonic muscle activity after 
auditory stimulus (hand clapping) over a suppressed EEG.   
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Table 1: Patients demographics. 1) Continuous background or only stimulus-induced 
discontinuities (categories a or b1 according to [10]). 2) as defined in [22]. 3) 
Documented only for 144 patients. 
 
 
  
 Favorable outcome 
Unfavorable 
outcome p-value 
    N 90 94 n.a. 
Female 16 (18%) 29 (31%) 0.039 
Age (±SD) [y] 61.3 (± 14.2) 65.6 (±15.5) 0.025 
Non-cardiac etiology 12 (13%) 31 (33%) 0.0016 
Asystole or pulseless electrical 
activity on site 18 (20%) 58 (62%) <0.001 
    Latency of EEG recording (±SD) [h] 20.5 (±6.3) 21.9 (±7.6) 0.22 
Continuous EEGs1 43 (48%) 18 (19%) < 0.001 
“highly malignant pattern” 2 
[suppressed/burst-suppression]  6 (7%) [0/6] 50 (53%) [17/33] < 0.001 
Baseline EMG activity present 54 (60%) 47 (50%) 0.17 
    Patients sedated with propofol 49 (54%) 39 (41%) 0.08 
Propofol dosis (±SD) [mg/kg/h] 2.3 (±1.1) 2.2 (±1.3) 0.36 
Patients sedated with midazolam 32 (36%) 25 (27%) 0.19 
Midazomal dosis (±SD) [mg/kg/h] 0.13 (±0.06) 0.10 (±0.05) 0.16 
Patients sedated with fentanyl 56 (62%) 44 (47%) 0.05 
Fentanyl dosis(±SD) [mg/kg/h]  1.15 (±0.7)  1.20 (±0.9)  0.75 
Patients with myorelaxants3 6/69 (9%) 5/75 (7%) 0.65 
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Table 2: Performance of reactivity for predicting favorable outcome (EEG-R, 
modification of EEG background after stimulus; EMG-R: modification of EMG 
activity after stimulus; EEG- and/or EMG-R: modification of EEG background and or 
EMG activity; 95% CI, 95%-confidence interval; PPV, positive predictive value; 
NPV, negative predictive value). 
 
 
  
Favorable 
outcome 
Accuracy (95% 
CI) 
Sensitivity 
(95% CI) 
Specificity (95% 
CI) PPV (95% CI) 
NPV (95% 
CI) 
EEG-R  72% (66-79)  86% (78-93) 60% (50-69)  67% (58-76)  81% (72-90) 
EMG-R 65% (58-72) 61% (51-71) 69% (60-78) 65% (55-76)  65% (56-74) 
EEG- and/or  
EMG-R  73% (67-80) 94% (90-99) 53% (43-63) 66% (58-74) 91% (83-99) 
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Table 3: Combining EEG background reactivity and continuity for predicting 
favorable or unfavorable outcome (95% CI: 95%-confidence interval; EEG-R: 
modification of EEG background after stimulus; EMG-R: modification of EMG 
activity after stimulus; highly malignant pattern: burst-suppression or suppressed 
background; PPV: positive predictive value; NPV: negative predictive value). 
 
Favorable outcome 
Accuracy 
(95% CI) 
Sensitivity (95% 
CI) 
Specificity (95% 
CI) 
PPV (95% CI) 
NPV (95% 
CI) 
Continuous background 65% (58-72) 48% (37-58) 81% (73-89) 70% (59-82) 62% (53-70) 
Continuous background or EEG-R 73% (67-80) 91% (85-97) 56% (46-66) 67% (58-75) 87% (78-95) 
Continuous background or EMG-R 69% (62-76) 74% (65-83) 64% (54-74) 66% (57-76) 72% (63-82) 
Continuous background or EEG-R 
or EMG-R 73% (67-80) 97% (93-100) 51% (41-61) 65% (57-73) 
94% (88-
100) 
      
Unfavorable outcome 
Accuracy 
(95% CI) 
Sensitivity (95% 
CI) 
Specificity (95% 
CI) 
PPV (95% CI) 
NPV (95% 
CI) 
Highly malignant pattern 73% (66-79) 53% (43-63) 93% (88-99) 89% (81-97) 66% (57-74) 
Highly malignant pattern without 
EEG-R 72% (66-79) 50% (40-60) 96% (91-100) 92% (85-100) 65% (57-73) 
Highly malignant pattern without 
EMG-R 71% (65-78) 46% (36-56) 98% (95-100) 96% (90-100) 63% (55-71) 
Highly malignant pattern without 
EEG-R or EMG-R 72% (65-78) 45% (35-55) 100% (100-100) 
100% (100-
100) 63% (55-71) 
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